Waaser steps up as CEO of Systagenix
This article was originally published in Clinica
Systagenix Wound Management (Gatwick, UK) has appointed Ernest Waaser CEO. Mr Waaser has led a number of large, multinational healthcare companies; he was most recently president of Teleflex Medical and prior to that, he was president and CEO of Hill-Rom. Mr Waaser replaces Steve Atkinson, who has been at the helm since Systagenix was created in December 2008 following the management buy-out of Ethicon's professional wound care business. The transaction was led by One Equity Partners. On leaving Systagenix, Mr Atkinson will continue to work with One Equity Partners as a consultant and advisor on medical device investments.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.